Researchers at the University of Arizona Health Sciences identified a new way to make opioids safer, increasing the ...

Checkpoint inhibitors can treat many different types of cancer. Its key to success lies in blocking one of cancer’s main ...

Zyversa Therapeutics Inc. announced it has selected obesity and its related metabolic complications as the lead indication ...

A research team led by Professor Ying Wai Chan from the School of Biological Sciences at The University of Hong Kong (HKU) ...

Boehringer Ingelheim is paying up to $1.3 billion for Nerio Therapeutics and a preclinical immune checkpoint inhibitor ...

On occasion, genetic mutations in guardian proteins can turn them from inhibitors into promoters of cancer. Unable to discern the change, the chaperones that guard them unfortunately provide them ...

Northwestern Medicine scientists have developed a new, more precise method to target proteins implicated in certain types of cancer, according to a study published in Nature Chemical Biology.

Back-to-back failures in psoriasis and Crohn’s disease have forced Ventyx Biosciences to abandon the development of its ...

Ventyx Bioscience has dropped its TYK2 inhibitor VTX958 after a Phase II Crohn’s disease ... VTX-958 acts by inhibiting ...

Their latest findings, published in Cell Reports, reveal the crucial role of a protein named FANCM in promoting resistance to ...